3/22/2022 7:56:17 AM
Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Neutral With $33 Price Target
3/7/2022 4:57:38 PM
Wedbush Is Cutting ANAPTYSBIO INC (ANAB) FY22 Rev. Estimate To 21.7 M From 24.4 M
3/7/2022 4:57:18 PM
Wedbush Is Lowering ANAPTYSBIO INC (ANAB) Q4 22 Rev. Estimate To 1.7 M From 2.6 M
3/7/2022 4:57:04 PM
Wedbush Is Cutting ANAPTYSBIO INC (ANAB) Q3 22 Rev. Estimate To 1.7 M From 2.4 M
3/7/2022 4:56:47 PM
Wedbush Is Cutting ANAPTYSBIO INC (ANAB) Q2 22 Rev. Estimate To 17.6 M From 18.5 M
3/7/2022 4:56:33 PM
Wedbush Is Cutting ANAPTYSBIO INC (ANAB) Q1 22 Rev. Estimate To 2.6 M From 3.3 M
3/7/2022 4:55:47 PM
Wedbush Is Lowering ANAPTYSBIO INC (ANAB) FY22 Estimate To -4.42 From -3.96
3/7/2022 4:55:21 PM
Wedbush Is Cutting ANAPTYSBIO INC (ANAB) Q4 22 Estimate To -1.37 From -1.24
3/7/2022 4:55:04 PM
Wedbush Is Lowering ANAPTYSBIO INC (ANAB) Q3 22 Estimate To -1.30 From -1.18
3/7/2022 4:54:34 PM
Wedbush Is Lowering ANAPTYSBIO INC (ANAB) Q2 22 Estimate To -0.66 From -0.54
3/7/2022 4:54:18 PM
Wedbush Is Cutting ANAPTYSBIO INC (ANAB) Q1 22 Estimate To -1.08 From -0.99
3/7/2022 4:53:10 PM
Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Neutral With $33 Down From $35 Price Target
6/6/2019 6:23:40 AM
Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Outperform With $146 Price Target
1/23/2019 7:19:34 AM
Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Outperform With $146 Price Target
9/18/2018 6:49:58 AM
Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Outperform With $138 Price Target
8/8/2018 10:14:03 AM
Wedbush Is Raising ANAPTYSBIO INC (ANAB) FY18 Estimate To -2.45 From -2.98
8/8/2018 10:13:44 AM
Wedbush Is Raising ANAPTYSBIO INC (ANAB) Q4 18 Estimate To -0.65 From -0.86